Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF

Neurobiology of Aging

Volumn 23, Issue 3, 2002, Pages 389-396

  Atack, John R ^a   Schapiro, Mark B ^b  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Acetylcholinesterase; Aging; Butyrylcholinesterase; Cerebrospinal fluid; Dementia of the Alzheimer type; Down syndrome; Inositol monophosphatase

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; ENZYME; INOSITOL; INOSITOL MONOPHOSPHATASE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; DOWN SYNDROME; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME REGULATION; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SPINAL CORD;

ACETYLCHOLINESTERASE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BUTYRYLCHOLINESTERASE; DOWN SYNDROME; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PHOSPHORIC MONOESTER HYDROLASES; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SPINAL PUNCTURE; TIME FACTORS;

EID: 0036228395     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00335-9     Document Type: Article

References (28)

1. Lithium, phosphatidylinositol signaling, and bipolar disorder - The role of inositol monophosphatase
2. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type
3. Cerebrospinal fluid gradients of acetylcholinesterase and butyrylcholinesterase activity in healthy aging
4. Characterization of inositol monophosphatase in human cerebrospinal fluid
5. Cerebrospinal fluid inositol monophosphatase: Elevated activity in depression and neuroleptic-treated schizophrenia
6. Cerebrospinal fluid production is normal in Down syndrome
7. Neural and developmental actions of lithium: A unifying hypothesis
8. Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years
9. 1H MRS study
10. Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment
11. CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia
12. CSF inositol does not predict antidepressant response to inositol
13. Cerebrospinal fluid production is reduced in healthy aging
14. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
15. Decreased CSF inositol monophosphatase activity after lithium treatment
16. Effect of age, sex steroids, brain region, and genetic strain on brain inositol monophosphatase activity
17. Ageing choroid plexus-cerebrospinal fluid system
18. +-sensitive enzymes and proceeds via inositol 4-phosphate
19. Dementia without mental retardation in mosaic translocation Down syndrome
20. Polyol profiles in Down syndrome - Myo-inositol, specifically, is elevated in the cerebrospinal fluid
21. Brain accumulation of myo-inositol in the trisomy 16 mouse, an animal model of Down's syndrome
22. Cerebrospinal fluid and plasma distribution of myo-insoitol and other polyols in Alzheimer disease
23. Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues
24. Alteration of myo-inositol monophophatase in Alzheimer's disease brains
25. Role of increased myo-inositol in the dementia of Down syndrome
26. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
27. Neurochemical analysis of cerebrospinal fluid
28. 31P NMR spectroscopic evidence of multiple aberrant biochemical pathways in murine trisomy 16 brain development